News & Updates

The past two decades have seen a disproportionate increase in cases of early-onset, well-differentiated neuroendocrine neoplasms (age 20‒34 years) compared with other age groups, driven primarily by midgut tumours, according to a recent study.

Photodynamic therapy using topically applied hypericin 0.25% is effective against early-stage patch and plaque lesions in patients with mycosis fungoides−cutaneous T-cell lymphoma, while having a favourable safety profile, as shown in the phase III FLASH trial.

Surgical treatment for metastatic disease of bone (MDB) at lower-volume hospitals is not associated with poorer survival or more readmissions, according to a study.

The addition of erlotinib to best supportive care (BSC) provided better survival benefit than BSC only in individuals with unresectable/metastatic gall bladder cancer (GBC) with poor performance status (PS), according to a phase II/III open-label study.

PartnerCARE, an online intervention designed to address mental health needs of caregiving partners of cancer patients, appears to be feasible and acceptable, a recent study has found. PartnerCARE also appears to be effective, inducing substantial improvements in psychological distress and anxiety.

A large proportion of cancer patients suffering from depressive symptoms cannot seem to effectively manage this burden on their own, particularly those who tend to avoid dealing with their own problems, reports a recent analysis.